Annual ROA
-49.33%
+1.06%+2.10%
31 December 2021
Summary:
Concert Pharmaceuticals annual return on assets is currently -49.33%, with the most recent change of +1.06% (+2.10%) on 31 December 2021. During the last 3 years, it has risen by +1.06% (+2.10%).CNCE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROA
-81.97%
+0.97%+1.17%
30 September 2022
Summary:
Concert Pharmaceuticals quarterly return on assets is currently -81.97%, with the most recent change of +0.97% (+1.17%) on 30 September 2022.CNCE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNCE ROA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +2.1% | -80.3% |
| 5 y5 years | -78.0% | -88.5% |
CNCE ROA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -180.5% | -213.8% |
Concert Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -81.97%(-1.2%) |
| June 2022 | - | -82.94%(+24.1%) |
| Mar 2022 | - | -66.83%(+23.8%) |
| Dec 2021 | -49.33%(-2.1%) | -53.98%(+18.8%) |
| Sept 2021 | - | -45.45%(+20.1%) |
| June 2021 | - | -37.85%(-20.1%) |
| Mar 2021 | - | -47.39%(+2.6%) |
| Dec 2020 | -50.39%(+6.4%) | -46.19%(+1.7%) |
| Sept 2020 | - | -45.42%(+4.1%) |
| June 2020 | - | -43.63%(-6.1%) |
| Mar 2020 | - | -46.46%(-1.1%) |
| Dec 2019 | -47.37%(+70.9%) | -46.98%(+8.0%) |
| Sept 2019 | - | -43.48%(+7.3%) |
| June 2019 | - | -40.52%(+14.0%) |
| Mar 2019 | - | -35.53%(+34.6%) |
| Dec 2018 | -27.72%(-145.2%) | -26.40%(+38.4%) |
| Sept 2018 | - | -19.08%(-135.9%) |
| June 2018 | - | 53.13%(-13.7%) |
| Mar 2018 | - | 61.53%(-7.1%) |
| Dec 2017 | 61.28% | 66.23%(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | 72.00%(-254.3%) |
| June 2017 | - | -46.67%(+3.8%) |
| Mar 2017 | - | -44.98%(+9.2%) |
| Dec 2016 | -41.01%(-296.2%) | -41.19%(+43.4%) |
| Sept 2016 | - | -28.72%(+15.1%) |
| June 2016 | - | -24.95%(-281.3%) |
| Mar 2016 | - | 13.76%(-25.7%) |
| Dec 2015 | 20.90%(-141.0%) | 18.53%(+52.9%) |
| Sept 2015 | - | 12.12%(-11.5%) |
| June 2015 | - | 13.69%(-141.9%) |
| Mar 2015 | - | -32.71%(-9.7%) |
| Dec 2014 | -51.03%(+207.2%) | -36.24%(+1.5%) |
| Sept 2014 | - | -35.70%(-2.4%) |
| June 2014 | - | -36.57%(+119.8%) |
| Mar 2014 | - | -16.64%(+11.6%) |
| Dec 2013 | -16.61%(-66.5%) | -14.91%(-22.5%) |
| Sept 2013 | - | -19.25%(+726.2%) |
| June 2013 | - | -2.33%(-91.9%) |
| Mar 2013 | - | -28.79%(+22.9%) |
| Dec 2012 | -49.54%(+116.2%) | -23.42% |
| Dec 2011 | -22.91% | - |
FAQ
- What is Concert Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for Concert Pharmaceuticals?
- What is Concert Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for Concert Pharmaceuticals?
What is Concert Pharmaceuticals annual return on assets?
The current annual ROA of CNCE is -49.33%
What is the all time high annual ROA for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high annual return on assets is 61.28%
What is Concert Pharmaceuticals quarterly return on assets?
The current quarterly ROA of CNCE is -81.97%
What is the all time high quarterly ROA for Concert Pharmaceuticals?
Concert Pharmaceuticals all-time high quarterly return on assets is 72.00%